info@marketresearchfuture.com   ๐Ÿ“ž  +1 (855) 661-4441(US)   ๐Ÿ“ž  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

US Medical Foods Market


ID: MRFR/Pharma/12139-CR | 100 Pages | Author: Garvit Vyas| December 2023

US Medical Foods Market Highlighted Trends & Dynamics


The US Medical Foods Market size was valued USD 8,402.15 million in 2021, is poised to demonstrate a 7.07% Compound Annual Growth Rate (CAGR) during the study period. This growth is underpinned by the region's high prevalence of chronic diseases like diabetes, cancer, and neurological disorders, necessitating specialized nutritional management. Notably, the National Cancer Institute projected around 1,806,590 new cancer cases in the US in 2020, with an estimated 606,520 associated deaths. The Centers for Disease Control and Prevention reported over 133 million diabetes cases in 2022, emphasizing the demand for tailored nutrition in disease management. The surge in cancer, diabetes, and other chronic conditions highlights the need for personalized nutrition solutions, and North America's robust healthcare infrastructure further propels market expansion. Moreover, the region witnesses an increased demand for medical food products targeting conditions such as phenylketonuria (PKU) and other rare diseases. The United States Food and Drug Administration (FDA) plays a pivotal role by establishing a regulatory framework for medical foods, fostering innovation among key market players. Additionally, the growing awareness of medical food benefits and favorable reimbursement policies contribute significantly to the market's upward trajectory. The comprehensive healthcare landscape and the prevalence of chronic diseases create an environment where personalized nutritional management becomes integral. The regulatory support from the FDA ensures that innovative medical food products catering to specific health conditions can enter the market, addressing unmet needs. This, coupled with increasing awareness among consumers about the advantages of medical foods, further fuels the growth momentum. The proactive reimbursement policies further incentivize the adoption of medical food products, creating a favorable market ecosystem in North America. As the region continues to grapple with the challenges posed by chronic diseases, the demand for specialized nutritional solutions is expected to sustain the positive growth trajectory in the medical foods market.

Report Attribute/Metric Details
Market Size 2022 USD 21.38 billion
Market Size 2023 USD 22.62 billion
Market Size 2032 USD 35.3 billion
Compound Annual Growth Rate (CAGR) 6.3% (2023-2032)
Base Year 2022
Forecast Period 2023-2032
Historical Data 2019 to 2021
Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered Nutritional Ingredients, Route of Administration, Form, Application, Distribution Channel, and, and Region
Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
Countries Covered The U.S, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled Danone SA (France), Abbott (US), Fresenius Kabi AG (Germany), TARGETED MEDICAL PHARMA INC (US), Metagenics LLC (US), Nestlรฉ (Switzerland), Reckitt Benckiser Group PLC (UK), Medtrition, Inc (US), Primus Pharmaceuticals, Inc (US), and Alfasigma USA, Inc (US)
Key Market Opportunities Increasing product launch initiatives and constant innovations in developing products
Key Market Dynamics Increasing prevalence of chronic diseases Growing nutritional deficiency among people Raising awareness about prebiotics and probiotic products


Leading companies partner with us for data-driven Insights.

client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.